Chekerov R

No ORCID on file · 4 papers in corpus · active 2019-2025

Study types

  • article 2

Condition tags

  • endometriosis 2
2025
The Charité protocol for surveillance, treatment and after-care management in women with Lynch syndrome.
Archives of gynecology and obstetrics ·doi:10.1007/s00404-025-08112-5

BackgroundLynch syndrome (LS) is the most common inherited cancer syndrome, caused by germline mutations in mismatch repair (MMR) genes such as MLH1, MSH2, MSH6, and PMS2. While primarily associated with colorectal cancer, LS significantly …

article 2022
HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients
BMC cancer ·doi:10.1186/s12885-022-09887-5

BACKGROUND: To evaluate the diagnostic value of adding human epididymis protein 4 (HE4), cancer antigen 125 (CA125) and risk of malignancy algorithm (ROMA) to ultrasound for detecting ovarian cancer in patients with a pelvic mass. METHODS:…

article 2021
Functional changes of immune cells: signal of immune tolerance of the ectopic lesions in endometriosis?
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2021.04.012

Research questionWhat is the potential role of immune cells and their inflammatory cytokines in the pathogenesis, development and establishment of endometriosis?DesignPeritoneal fluid from 59 women (43 with endometriosis and 16 controls) wh…

2019
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer.
Cells ·doi:10.3390/cells8070713

Detection of epithelial ovarian cancer (EOC) poses a critical medical challenge. However, novel biomarkers for diagnosis remain to be discovered. Therefore, innovative approaches are of the utmost importance for patient outcome. Here, we pr…